Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | MME | P08473 | 1/20 | 0.42 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17766327 | 0.78 | GRIN2D (0.48) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL17766328 | 0.77 | TSHR (0.44) | MMEACEF2LMNAHPGD | |
| SCHEMBL4396914 | 0.74 | CASR (0.56) | KMT2ANPC1ALDH1A1RAB9AANPEP | |
| SCHEMBL4779401 | 0.68 | P2RX7 (0.46) | KMT2ANPC1P2RX7ALDH1A1RAB9A | |
| SCHEMBL28787753 | 0.67 | KMT2A (0.39) | KMT2ANPC1P2RX7ALDH1A1RAB9A | |
| SCHEMBL27750762 | 0.67 | CYP2D6 (0.50) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL11134972 | 0.67 | KMT2A (0.51) | KMT2ACA12CA1CA2CA9 | |
| SCHEMBL4779366 | 0.67 | P2RX7 (0.45) | KMT2ANPC1P2RX7ALDH1A1RAB9A | |
| SCHEMBL625326 | 0.66 | CYP2C9 (0.49) | NPC1P2RX7ALDH1A1RAB9A | |
| SCHEMBL29140939 | 0.66 | HDAC1 (0.64) | KMT2ACA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9670148-B2 | Method for producing meta-xylylenediisocyanates | MITSUI CHEMICALS, INC. (JP) | 2017-06-06 | — | — | US | disclosed |
| US-9670148-B2 | Method for producing meta-xylylenediisocyanates | MITSUI CHEMICALS, INC. (JP) | 2017-06-06 | — | — | US | disclosed |
| US-20160145201-A1 | METHOD FOR PRODUCING META-XYLYLENEDIISOCYANATES | MITSUI CHEMICALS, INC. (JP) | 2016-05-26 | — | — | US | disclosed |
| US-20160145201-A1 | METHOD FOR PRODUCING META-XYLYLENEDIISOCYANATES | MITSUI CHEMICALS, INC. (JP) | 2016-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160145201-A1 | METHOD FOR PRODUCING META-XYLYLENEDIISOCYANATES | NAT1, XDH, CYP1A1 | KMT2A 751/4885CA12 1607/4885CA1 676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.